Image

Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease

Efficacy of Paper-based Cognitive Training in Vietnamese Patients With Early Alzheimer's Disease

Non Recruiting
60-80 years
All
Phase N/A

Powered by AI

Overview

The purpose of this study is to assess the efficacy of paper-based cognitive training in Vietnamese patients with early Alzheimer's disease

Eligibility

Inclusion Criteria:

  • For patient:
    • Diagnosis of Probable Alzheimer's Disease per DSM-5 criteria;
    • In the early stage of AD (MMSE from 20 to 25);
    • Age from 60 - 80 years old;
    • Had greater than 5 years of formal education.
  • For Caregiver:
    • Members (including, but not limited to partners, children, relatives, lived-in helper of the patient) that are important for care delivery and provide care-related tasks (eg personal care, eating, cooking, cleaning) and everyday decision making to the patients. They are not required to live together or spend a specific amount of time with the patients;
    • Older than 18 years of age;
    • Possess adequate Vietnamese language skills and no cognitive impairment to conduct interview and evaluation

Exclusion Criteria:

  • For patient:
    • Patients with concomitant diseases (heart failure, kidney failure, liver failure or thyroid diseases) that affect cognitive functions;
    • Diagnosed with significant neurologic disease other than AD (Parkinson's disease, multi-infarct dementia, schizophrenia, history of significant head trauma followed by persistent neurologic defaults, …), major depression within the past 1 year, or taking psychoactive medications (antidepressants with significant anticholinergic side effects, neuroleptics, chronic anxiolytics or sedative hypnotics, etc) within the past 1 month;
    • Having major visual, auditory, reading, or writing impairments;
    • Patients and/or caregivers who decline to participate.
  • For cargiver:
    • Having subjective complaints of cognitive impairment prevents them from understanding the instruction from the research team;
    • Having significant visual, auditory, reading, or writing impairments;
    • Caregivers who decline to participate

Study details
    Alzheimer Disease

NCT04949750

University of Medicine and Pharmacy at Ho Chi Minh City

20 August 2025

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.